Product Information
GNP NICOTINE 4 MG CHEWING GUM is a generic product labeled by AmerisourceBergen, priced at $0.2866 per EA under NDC 46122044958. Its NADAC has been published 294 times since Feb 17, 2021.
FDA first approved this application on Feb 26, 2016.
Strength
4 mg/1
Manufacturer
AmerisourceBergenNDC
46122044958
Classification
Generic
Dosage Form
GUM, CHEWING
Route
BUCCAL
Effective Date
9/23/2026
Active Ingredients
NICOTINEApproval Type
Generic (ANDA)
FDA Application
ANDA204833FDA Approved
2/26/2016
On Market Since
1/9/2018
Pharmacological Classes
Price Statistics
The NADAC for GNP NICOTINE 4 MG CHEWING GUM has been published 294 times since Feb 17, 2021, and over the history we have for it it has risen 3.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2866 per EA |
|---|---|
| All-time high | $0.3335 (Feb 14, 2024) |
| All-time low | $0.2172 (Apr 21, 2021) |
| 52-week high | $0.2866 |
| 52-week low | $0.2687 |
| Median price | $0.2743 |
| Average price | $0.2717 |
| Largest weekly change | +26.6% (Aug 21, 2024) |
| Weeks tracked | 294 |
| Tracking since | Feb 17, 2021 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nicotine Polacrilex market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Nicotinic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP NICOTINE 4 MG CHEWING GUM?
The current National Average Drug Acquisition Cost (NADAC) for GNP NICOTINE 4 MG CHEWING GUM, manufactured by AmerisourceBergen, is $0.2866 per EA (NDC 46122044958), effective Sep 30, 2026.
How has the price of GNP NICOTINE 4 MG CHEWING GUM changed over time?
Over the history we have for it, the NADAC for GNP NICOTINE 4 MG CHEWING GUM has risen 3.0%. It has been tracked across 294 weekly CMS publications since Feb 17, 2021.
What are the highest and lowest recorded NADAC prices for GNP NICOTINE 4 MG CHEWING GUM?
Since Feb 17, 2021, the NADAC for GNP NICOTINE 4 MG CHEWING GUM has ranged from a low of $0.2172 (Apr 21, 2021) to a high of $0.3335 (Feb 14, 2024), with a median of $0.2743 per EA.
Are there cheaper alternatives to GNP NICOTINE 4 MG CHEWING GUM?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NICOTINE 4 MG CHEWING GUM, is $0.2323 per EA — about 19% below GNP NICOTINE 4 MG CHEWING GUM.
Who manufactures GNP NICOTINE 4 MG CHEWING GUM?
GNP NICOTINE 4 MG CHEWING GUM (NDC 46122044958) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.